• Home
  • Contact Us
  • Try it!
  • Graphs
  • Publications
  • Blog

Follow us

Recent Posts

  • NEWROAD final meeting April 28, 2026
  • Biovista Vizit New Corpus: ClinicalTrials.gov September 16, 2025
  • Biovista Vizit New Corpus: MATISSE (a SoftMining algorithm) May 13, 2025
  • Biovista Vizit New Corpus: HPO March 4, 2025
  • Biovista Vizit January 2025 Release – AOP Features January 30, 2025

Biovista Vizit

Biovista Vizit

  • Try it!
  • Graphs
  • Publications
  • Blog

Immune checkpoint blockade in cancer immunotherapy

August 28, 2018Cancer, Cancer Immunotherapy, Vizit Graphs
Immune checkpoint blockade in cancer immunotherapyChristos Andronis2020-08-03T13:49:12-04:00
Immune checkpoint blockade in cancer immunotherapy

Explore immune checkpoint blockade (PD-1, CTLA-4) in cancer immunotherapy with Biovista Vizit.

Explore the live graph.

Tags: ABATACEPT, CANCER, CTLA4, CYTOKINE PRODUCTION, IMMUNE RESPONSE, IPILIMUMAB, LYMPHOCYTE ACTIVATION, MELANOMA, NIVOLUMAB, PD-1, PEMBROLIZUMAB, PROGRAMMED CELL DEATH, REGULATORY T-LYMPHOCYTES, T CELL ACTIVATION

Post navigation

← Circadian rhythm genes
Drugs for Parkinson’s and Alzheimer’s →
TGF-BETA TUMOR VIRUS DISEASES VEGFA TISSUE DEVELOPMENT THROMBIN THY-1 ANTIGENS THORAX VASODILATION VIRAL RELEASE FROM HOST CELL VITAMIN D TAUOPATHIES TUMOR PROGRESSION UCHL1 PROTEIN TH17 CELLS TRACHEA THROMBOCYTOPENIA VGF PROTEIN TRANSLATION ULCERATIVE COLITIS X-RAY COMPUTED TOMOGRAPHY TRASTUZUMAB TAU THROMBOSIS VEINS UBIQUITINATION TP53 TRANSPORT TUMOR GROWTH VEGF Uberon VASOCONSTRICTION VASCULAR TROGLITAZONE TMPRSS2 TREPONEMA DENTICOLA TYPE 2 DIABETES VERO CELLS WOUND HEALING TROPISM TIMELESS TECFIDERA TARGET LESION IDENTIFICATION

© 2026 Biovista Vizit All Rights Reserved.

Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}